French biotech stock soars 31% after new data on experimental medicine

🇫🇷 CNBC (FR) —
French biotech stock soars 31% after new data on experimental medicine

AI Summary

Shares of the French biotech firm Abivax surged 31% after releasing new positive data on its experimental drug for bowel disease. The stock market reacted strongly to the medical progress.

Shares of French biotech company Abivax soared Tuesday after it released fresh data on its lead drug for bowel disease.

Markets Health Abivax biotech stock surge experimental medicine bowel disease clinical data

Read original source →